A role for nitric oxide and for nitric oxide synthases in tumor biology

Forum on Immunopathological Diseases and Therapeutics

Volumn 3, Issue 2, 2012, Pages 169-182

  De Oliveira, Graciele A ^a   Rosa, Heloísa ^a   Reis, Adriana Karla C A ^a   Stern, Arnold ^b   Monteiro, Hugo P ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer biology; Nitric oxide; Nitric oxide synthases; Protein kinases; Protein phosphatases; Redox signaling; S nitrosothiols; S nitrosylation; Tyrosine phosphorylation

Indexed keywords

ARGINASE; ARGINASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE KINASE; RAS PROTEIN; UNCLASSIFIED DRUG;

CANCER GROWTH; CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; HUMAN; MOLECULAR INTERACTION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THYROID FOLLICULAR CARCINOMA;

EID: 84872296267     PISSN: 21518017     EISSN: 21518025     Source Type: Journal    
DOI: 10.1615/ForumImmunDisTher.2012006134     Document Type: Conference Paper

References (73)

1. Fukuto JM, Carrington SJ, Tantillo DJ, Harrison JG, Ignarro LJ, Freeman BA, Chen A, Wink DA. Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species. Chem Res Toxicol. 2012;25:769-793.
2. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A. 1977;74:3203-3207. (Pubitemid 8180317)
3. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro L. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res. 1979;5:211-224. (Pubitemid 9246716)
4. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A.1987;84:9265-9269.
5. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376. (Pubitemid 11169009)
6. Baek KJ, Thiel BA, Lucas S, Stuehr DJ. Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem. 1993;268:21120-21129. (Pubitemid 23292298)
7. Hurshman AR, Krebs C, Edmondson DE, Huynh BH, Marletta MA. Formation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygen. Biochemistry. 1999;38:15689-15696.
8. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994;298(Pt 2):249-258. (Pubitemid 24072462)
9. Ghafourifar P, Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett. 1997;418:291-296. (Pubitemid 27515942)
10. Marks GS, McLaughlin BE, Jimmo SL, Poklewska-Koziell M, Bien JF, Nakatsu K. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate. Drug Metab Dispos. 1995;23:1248-1252.
11. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626-632. (Pubitemid 23274719)
12. Gutierrez HH, Nieves B, Chumley P, Rivera A, Freeman BA. Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Free Rad Biol Med. 1996;21:43-52. (Pubitemid 26230404)
13. Wang PG, Xian M, Tang X, Wu X, Wen Z, Cai T, Janczuk AJ. Nitric oxide donors: chemical activities and biological applications. Chem Rev. 2002;102:1091-1134. (Pubitemid 35377604)
14. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nature Rev Mol Cell Biol. 2005;6:150-166. (Pubitemid 40215810)
15. Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Rad Biol Med. 1998;25:434-456. (Pubitemid 28390299)
16. Martínez-Ruiz A, Cadenas S, Lamas S. Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. Free Rad Biol Med. 2011;51:17-29.
17. Kots AY, Bian K, Murad F. Nitric oxide and cyclic GMP signaling pathway as a focus for drug development. Curr Med Chem. 2011;18:3299-3230.
18. Monteiro HP, Arai RJ, Travassos, LR. Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. Antiox Redox Signal. 2008;10:843-889. (Pubitemid 351301369)
19. Hess DT, Stamler JS. Regulation by S-nitrosylation of protein post-translational modification. J Biol Chem. 2012;287:4411-4418.
20. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342-348. (Pubitemid 32467043)
21. Fidler IJ. Review: biologic heterogeneity of cancer metastases. Breast Cancer Res Treat. 1987;9:17-26. (Pubitemid 17111467)
22. Fidler IJ, Talmadge JE. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res. 1986;46:5167-5171. (Pubitemid 16008283)
23. Weinberg RA. The Biology of Cancer. New York, NY: Garland Science; 2007.
24. Dimmeler S, Zeiher AM. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide. 1997;1:275-281. (Pubitemid 28078114)
25. Wink DA, Ridnour LA, Hussain SP, Harris CC. The reemergence of nitric oxide and cancer. Nitric Oxide. 2008;19:65-67. (Pubitemid 351970245)
26. Hibbs JB Jr, Taintor RR, Vavrin Z. Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem Biophys Res Commun. 1984;123:716-723. (Pubitemid 14010149)
27. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nature Rev Cancer. 2001;6:521-534.
28. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Sem Cancer Biol. 2005;15:277-289. (Pubitemid 41058773)
29. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A. 1995;92:4392-4396.
30. Xie K, Huang S, Dong Z, Juang D-H, Wang Y, Fidler IJ. Destruction of bystander cells by tumor cells transfected with iNOS gene. J Natl Cancer Inst. 1997;89:421-427. (Pubitemid 27136733)
31. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases.Cell.2010;141:1117-1134.
32. Erpel T, Courtneidge SA. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol. 1995;7:176-182.
33. Martin SG. The hunting of the Src. Nature Rev Mol Cell Biol. 2001;2:467-475.
34. Roskoski R Jr. Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun. 2004;324:1155-1164.
35. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nature Rev Cancer. 2005;5:505-515. (Pubitemid 40942827)
36. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT. Autophosphorylation of the focal adhesion kinase pp125FAK directs SH2-dependent binding of pp60Src. Mol Cell Biol. 1994;14:1680-1688.
37. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD. FAK integrates growth-factor and integrin signals to promote cell migration. Nature Cell Biol. 2000;2:249-257.
38. Grisaru-Granovsky S, Salah Z, Maoz M, Pruss D, Beller U, Bar-Shavit R. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malign human ovarian tissue samples. Int J Cancer. 2005;113:372-378. (Pubitemid 40038703)
39. Sonoda Y, Matsumoto Y, Funakoshi M, Yamamoto D, Hanks SK, Kasahara T. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemia cell line, HL-60. J Biol Chem. 2000;275:16309-16315. (Pubitemid 30366946)
40. Matkowskyj KA, Keller K, Glover S, Kornberg L, Tran-Son-Tay R, Benya RV. Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated on tyrosines 397 and 407. J Histochem Cytochem. 2003;51:1041-1048. (Pubitemid 36919981)
41. Peranovich TMS, da Silva AM, Fries DM, Stern A, Monteiro HP. Nitric oxide stimulates tyrosine phosphorylation in murine fibroblasts in the absence and presence of epidermal growth factor. Biochem J. 1995;305:613-619.
42. Monteiro HP, Gruia-Gray J, Peranovich TMS, Barbosa de Oliveira LC, Stern A. Nitric oxide stimulates tyrosine phosphorylation of focal adhesion kinase, Src kinase, and mitogen-activated protein kinases in murine fibroblasts. Free Rad Biol Med. 2000;28:174-182. (Pubitemid 30084009)
43. Curcio MF, Batista WL, Linares E, Nascimento FD, Moraes MS, Borges RE, Sap J, Stern A, Monteiro HP. Regulatory effects of nitric oxide on Src kinase, FAK, p130Cas, and receptor protein tyrosine phosphatase α (PTP-α): a role for the cellular redox environment. Antiox Redox Signal. 2010;13:109-125.
44. Harder KW, Moller NPH, Peacock JW, Jirik FR. Protein tyrosine phosphatase α regulates Src family kinases and alters cell-substratum adhesion. J Biol Chem. 1998;273:31890-31900. (Pubitemid 29177126)
45. Ardini E, Agresti R, Tagliabue E, Greco M, Aiello P, Yang L-T, Menard S, Sap J. Expression of protein tyrosine phosphatase alpha (RPTPα) in human breast cancer correlates with low tumor grade and inhibits tumor cell growth in vitro and in vivo. Oncogene. 2000;19:4979-4987.
46. Glynn SA, Boersmma BJ, Dorsey TH, Yi M, Yfantis HG, Ridnour LA, Marin DN, Switzer CH, Hudson RS, Wink DA, Lee, DH, Stephens RM, Ambs S. Increased NOS2 predicts poor survival in estrogen-receptor-negative breast cancer patients. J Clin Invest. 2010;120:3843-3854.
47. Parada LF, Tabin CJ, Shih C, Weinberg RA. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature. 1982;297:474-478. (Pubitemid 12007526)
48. Santos E, Tronick SR, Aaronson SA, Pulciani S, Barbacid M. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB and Harvey-MSV transforming genes. Nature. 1982;298:343-347. (Pubitemid 12044286)
49. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J. 2000;351:289-305.
50. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev. 2001;81:153-208. (Pubitemid 32098004)
51. Heo J. Redox control of GTPases: from molecular mechanisms to functional significance in health and disease. Antiox Redox Signal. 2011;14:689-724.
52. Lander HM, Ogiste JS, Pearce SFA, Levi R, Novogrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21Ras. J Biol Chem. 1995;270:7017-7020.
53. Williams JG, Pappu K, Campbell SL. Structural and biochemical studies of p21Ras s-nitrosylation and nitric oxide-mediated guanine nucleotide exchange. Proc Natl Acad Sci U S A. 2003;100:6376-6381. (Pubitemid 36666589)
54. Rocha Oliveira CJ, Schindler F, Ventura AM, Moraes MS, Arai RJ, Debbas V, Stern A, Monteiro HP. Nitric oxide and cGMP activate the Ras-MAP kinase pathway stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells. Free Rad Biol Med. 2003;35:381-396. (Pubitemid 37289168)
55. Rocha Oliveira CJ, Curcio MF, Moraes MS, Tsujita M, Travassos LR, Stern A, Monteiro HP. The low molecular weight S-nitrosothiol, S-nitroso-N- acetylpenicillamine, promotes cell cycle progression in rabbit aortic endothelial cells. Nitric Oxide. 2008;18:241-255.
56. Pervin S, Singh R, Hernandez E, Wu G, Chaudhuri G. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway. Cancer Res. 2007;67:289-299. (Pubitemid 46142787)
57. Lim KH, Ancrile BB, Kashatus DF, Counter CM. Tumour maintenance is mediated by eNOS. Nature. 2008;452:646-649. (Pubitemid 351483359)
58. Sousa MSA, Latini FRM, Monteiro HP, Cerutti JM. Arginase 2 and nitric oxide synthase; pathways associated with the pathogenesis of thyroid tumors. Free Rad Biol Med. 2010;49;997-1007.
59. Li H, Meininger CJ, Hawker JR Jr, Haynes TE, Kepka-Lenhart D, Mistry S, Morris Jr SM, Wu G. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab. 2001;280:E75-E82.
60. Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, Riggins GJ. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest. 2004;113:1234-1242. (Pubitemid 38544109)
61. Aranda E, López-Pedrera C, De La Haba-Rodriguez JR, Rodriguez-Ariza A. Nitric oxide and cancer: the emerging role of s-nitrosylation. Curr Mol Med. 2012;12:50-67.
62. Wang Z. Protein s-nitrosylation and cancer. Canc Lett. 2012;320:123-129.
63. Eu JP, Liu L, Zeng M, Stamler JS. An apoptotic model for nitrosative stress. Biochemistry. 2000;39:1040-1047. (Pubitemid 30075332)
64. Albina JE, Cui S, Mateo RB, Reichner JS, Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol. 1993;150:5080-5085. (Pubitemid 23150375)
65. Figueroa S, Oset-Gasque MJ, Arce C, Martinez-Honduvilla CJ, Gonzalez MP. Mitochondrial involvement in nitric oxide-induced cellular death in cortical neurons in culture. J Neurosci Res. 2006;83:441-449. (Pubitemid 43184407)
66. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA. S-Nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science. 2002;297:1186-1190. (Pubitemid 36193354)
67. Brune B, Von Knethen A, Sandau KB. Nitric oxide (NO): an effector of apoptosis. Cell Death Differ. 1999;6:969-975. (Pubitemid 29520798)
68. Mocellin S. Nitric oxide: cancer target or anticancer agent? Curr Cancer Drug Target. 2009;9:214-236.
69. Millet A, Bettaieb A, Renaud F, Prevotat L, Hammann A, Solary E, Mignotte B, Jeannin JF. Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells. Gastroenterology. 2002;123:235-246. (Pubitemid 34747544)
70. Bonavida B, Baritaki S. Dual role of NO donors in the reversal of tumor cell resistance and EMT: downregulation of the NF-κB/Snail/YY1/RKIP circuitry. Nitric Oxide. 2011;24:1-7.
71. Tsujita M, Batista WL, Ogata FT, Stern A, Monteiro HP, Arai RJ. The nitric-oxide-sensitive p21Ras-ERK pathway mediates s-nitrosoglutathione-induced apoptosis. Biochem Biophys Res Commun. 2008;369:1001-1006.
72. Monteiro HP, Silva EF, Stern A. Nitric oxide: a potential inducer of adhesion-related apoptosis - anoikis. Nitric Oxide. 2004;10:1-10. (Pubitemid 38410889)
73. Costa PE, Batista WL, Curcio MF, Moraes MS, Borges RE, Nascimento PA, Travassos LR, Monteiro HP. Protein tyrosine phosphatase alpha regulates cell detachment and cell death profiles induced by nitric oxide donors in the A431 human carcinoma cell line. Redox Report. 2011;16:27-37.